Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

This publication has 33 references indexed in Scilit:

• Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases
  The Lancet Neurology, 2011
• Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients
  Lupus, 2009
• Proof of concept studies for tissue-protective agents in multiple sclerosis
  Multiple Sclerosis Journal, 2009
• Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans
  The International Journal of Cell Cloning, 2009
• Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis
  Zeitschrift für Neurologie, 2009
• Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosis
  Glia, 2009
• Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
  New England Journal of Medicine, 2008
• Multiple sclerosis
  The Lancet, 2008
• The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair
  Journal of Cellular Physiology, 2008
• Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
  Blood, 2005